Clinitech Laboratory Ltd vs Take Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 23, 2026

Key Highlights

The Latest Trading Price of Clinitech Laboratory Ltd is ₹ 32 as of 07 Oct 15:30 . The P/E Ratio of Clinitech Laboratory Ltd changed from 23.3 on March 2025 to 19.1 on March 2026 . This represents a CAGR of -9.46% over 2 yearsThe P/E Ratio of Take Solutions Ltd changed from 2.6 on March 2025 to 54.3 on March 2026 . This represents a CAGR of 357.00% over 2 years The Market Cap of Clinitech Laboratory Ltd changed from ₹ 9.18 crore on March 2025 to ₹ 7.99 crore on March 2026 . This represents a CAGR of -6.71% over 2 yearsThe Market Cap of Take Solutions Ltd changed from ₹ 664.96 crore on March 2021 to ₹ 586.26 crore on March 2026 . This represents a CAGR of -2.08% over 6 years The revenue of Clinitech Laboratory Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Take Solutions Ltd for the Jun '26 is ₹ 31.7 crore as compare to the Mar '26 revenue of ₹ 59.37 crore. This represent the decline of -46.61% The ebitda of Clinitech Laboratory Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Take Solutions Ltd for the Jun '26 is ₹ 1.06 crore as compare to the Mar '26 ebitda of ₹ 4.36 crore. This represent the decline of -75.69% The net profit of Clinitech Laboratory Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of Take Solutions Ltd changed from ₹ -3.75 crore to ₹ 1.06 crore over 9 quarters. This represents a CAGR of NaN% The Dividend Payout of Clinitech Laboratory Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Take Solutions Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Clinitech Laboratory Ltd

Clinitech Laboratory Limited was incorporated as Clinitech Laboratory Private Limited on March 19, 2010 with the Registrar of Companies, Mumbai.
The status of Company was changed to Public Limited and the name of Company changed to Clinitech Laboratory Limited through fresh certificate of incorporation upon conversion on August 25, 2023 was issued by the Registrar of Companies, Mumbai.
Company is in the business of healthcare services providing superior quality services such as pathology testing laboratories, diagnostic centers, scan centers, X-ray and ECG clinics, etc. The Company established a new Lab in Kalyan in 2012, NABL Accreditation at Airoli Centre in 2016, a new Lab at Thane in 2018.
Besides these, the Company conduct more than 150 tests including Biochemistry, Immunology, Hematology, Molecular Biology tests, urine analysis, Serology, Microbiology and Histopathology tests.

About Take Solutions Ltd

Take Solutions Limited was incorporated on December 20, 2000.
The Company has been promoted by a team of domain experts in the supply chain management sector of the software industry. TAKE Solutions delivers domain-intensive services and solutions in Life Sciences, Software and Information Technology.
In the fast-growing Life Sciences space, the Company offers clients a unique combination of full-service Clinical, Regulatory and Safety services backed by unique technology expertise.
Its global roster of clients includes large and small innovator biopharmaceutical companies as well as generics manufacturers.
As of March 31, 2025, TAKE Solutions Pte Ltd owned 52.90% of the Company's equity share capital and has the ability to control its operating and financial policies. In Supply Chain Management, TAKE through its subsidiaries focuses on niche engineering services, supply chain collaboration and product re-engineering.

FAQs for the comparison of Clinitech Laboratory Ltd and Take Solutions Ltd

Which company has a larger market capitalization, Clinitech Laboratory Ltd or Take Solutions Ltd?

Market cap of Clinitech Laboratory Ltd is 7 Cr while Market cap of Take Solutions Ltd is 161 Cr

What are the key factors driving the stock performance of Clinitech Laboratory Ltd and Take Solutions Ltd?

The stock performance of Clinitech Laboratory Ltd and Take Solutions Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Clinitech Laboratory Ltd and Take Solutions Ltd?

As of October 23, 2026, the Clinitech Laboratory Ltd stock price is INR ₹32.0. On the other hand, Take Solutions Ltd stock price is INR ₹10.93.

How do dividend payouts of Clinitech Laboratory Ltd and Take Solutions Ltd compare?

To compare the dividend payouts of Clinitech Laboratory Ltd and Take Solutions Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.